Alzheimer’s progression in Down syndrome appears similar to other genetic, early onset forms of the disease


Amyloid plaques—protein clumps that are one of the hallmarks of Alzheimer’s disease—occur at roughly the same level in the brains of people with Down syndrome who have Alzheimer’s as they do in people with forms of hereditary, early-onset Alzheimer’s, according to research funded by the National Institutes of Health. Based on the largest study of its kind to date, the findings suggest that individuals with Alzheimer’s and Down syndrome may benefit from participating in studies on Alzheimer’s therapies aimed at slowing formation of amyloid plaques.

Twitter’s legacy ‘verified’ checkmarks are going away in a few months

Previous article

Shaping the sport of kings: Key genes linked to successful racehorses identified by international team

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations